# Effectiveness and Safety of TENS Therapy for Premature Ejaculation

> **NCT06425224** · PHASE3 · RECRUITING · sponsor: **Boston Medical Group** · enrollment: 129 (estimated)

## Conditions studied

- Premature Ejaculation
- Sex Disorder
- TEN

## Interventions

- **DEVICE:** Tens therapy
- **DRUG:** Dapoxetine placebo
- **DRUG:** Standard treatment (dapoxetine 30 mg as needed)
- **DEVICE:** Placebo therapy

## Key facts

- **NCT ID:** NCT06425224
- **Lead sponsor:** Boston Medical Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-15
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 129 (ESTIMATED)
- **Last updated:** 2024-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06425224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06425224, "Effectiveness and Safety of TENS Therapy for Premature Ejaculation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06425224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*